GLAXF News and Press, GlaxoSmithKline Plc From 08/11/20

Foreword This article is based on five Kiplinger investing articles, plus one from Barron's Weekly, aimed at survival qualities endemic to our times: Pros' Picks: The 15 Best Nasdaq Stocks , by Dan Burrows, published 5/13/20, "screened the Nasdaq Composite for stocks followed by a m...

Quick Take CureVac ( CVAC ) intends to raise $200 million from the sale of its common stock in an IPO, plus another $118 million from a concurrent private placement, according to an amended registration statement . The company is advancing a number of drug development and gene therapy pro...

Introduction After I first published the article " The Coming Stock Market Crash - Smart Money Is Already Ringing The Death Bell " exclusively on my TEV blog and then here , it became my most read article ever on Seeking Alpha. In the article, I pointed out how massively the net assets in...

Original post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Quick Take CureVac B.V. ( CVAC ) has filed to raise $100 million in an IPO of its common shares, according to an F-1 registration statement . The firm is developing a wide range of treatments, vaccines and therapies based on messenger RNA technologies. CVAC has developed extensive colla...

Quick Take Checkmate Pharmaceuticals ( CMPI ) intends to raise $75 million from the sale of its common stock stock in an IPO, according to an amended registration statement . The company is advancing a biologic particle treatment for melanomas and head & neck squamous cell carcinomas....

Quick Take Checkmate Pharmaceuticals ( CMPI ) has filed to raise $75 million in an IPO of its common stock, according to an S-1 registration statement . The company is a clinical stage biopharma advancing a drug treatment candidate for melanoma and head & neck cancer. CMPI has produ...

GlaxoSmithKline PLC (GSK) Q2 2020 Earnings Conference Call July 29, 2020, 09:00 ET Company Participants Sarah Elton-Farr - Head, IR Emma Walmsley - CEO & Director Iain Mackay - CFO & Executive Director Hal Barron - Chief Scientific Officer, President of R&D and Dire...

The following slide deck was published by GlaxoSmithKline plc in conjunction with their 2020 Q2 earnings Read more ...

Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test now using the top four forensic algorithms applied to detect bankruptcy risk, earnings manipulation, and financial irregularities. This forward testing study co...